Volume 21, Issue 3 (December 1997)
Research in Medicine 1997, 21(3): 25-33 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khaje Karameddini M, Jahanshahi A R. The Introducing of Choice Antibiotic and New Differential Diagnosis Test for Staph. Epidermidis. Research in Medicine 1997; 21 (3) :25-33
URL: http://pejouhesh.sbmu.ac.ir/article-1-2273-en.html
URL: http://pejouhesh.sbmu.ac.ir/article-1-2273-en.html
Department of Virology, Ghaem University Hospital, Mashhad University of Medical Sciences, Tehran, Iran.
Abstract: (1253 Views)
In this research, for the first time in Iran, Deferoxamine test for differential diagnosis between Staph. epidermidis and Staph. hominis of other grampositive cocci is introduced. Besides, the comparative results of the susceptibility rates of Staph. aureus (220 Spp.) and Enterococci ( 110 Spp.) to a new glycopeptide antibiotic (SK&Fl04662) and other 12 antibiotics are presented by Disk-Agar Diffusion Method.
Staph. epidermidis species were completely susceptible (100%) and very specific (>90%) to deferoxamine disks (100, 1000, 2000 mcg). All of the gram-positive cocci were resistant to deferoxamine. Staph. epidermidis species were susceptible to moxalactam, ciprofloxacin and Enterococci species were susceptible to moxalactam, mezlocillin and sisomycin. However, Staph. epidermidis and Enterococci were completely susceptible (100%) to SK&F104662 antibiotic and vancomycin.
Staph. epidermidis species were completely susceptible (100%) and very specific (>90%) to deferoxamine disks (100, 1000, 2000 mcg). All of the gram-positive cocci were resistant to deferoxamine. Staph. epidermidis species were susceptible to moxalactam, ciprofloxacin and Enterococci species were susceptible to moxalactam, mezlocillin and sisomycin. However, Staph. epidermidis and Enterococci were completely susceptible (100%) to SK&F104662 antibiotic and vancomycin.
Type of Study: Original |
Subject:
Microbiology
Received: 2020/02/22 | Accepted: 2020/02/22 | Published: 2020/02/22
Received: 2020/02/22 | Accepted: 2020/02/22 | Published: 2020/02/22
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This Journal is licensed under a Creative Commons Attribution 4.0 International License | Research in Medicine
Designed & Developed by : Yektaweb